Comparative safety analysis of antiinterleukin-4/interleukin-13 inhibitors and Janus Kinase inhibitors in atopic dermatitis

被引：1
|
作者：
Bao, Aaron [1 ]
Su, Hsing-Jou [1 ]
Wan, Joy [1 ]
机构：
[1] Johns Hopkins Univ, Sch Med, Dept Dermatol, 200 N Wolfe St,Suite 2107, Baltimore, MD 21287 USA
来源：
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2024年 / 91卷 / 04期
基金：
美国国家卫生研究院;
关键词：
D O I：
10.1016/j.jaad.2024.06.064
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：768 / 771
页数：4
相关论文
共 50 条
  • [21] Efficacy of Janus kinase inhibitors in the treatment of psoriasiform atopic dermatitis
    Napolitano, Maddalena
    Foggia, Luciano
    Patruno, Cataldo
    Gallo, Lucia
    Tommasino, Nello
    Cecere, Daniele
    Megna, Matteo
    CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2024, 49 (10) : 1232 - 1234
  • [22] Janus Kinase Inhibitors in the Treatment of Atopic Dermatitis: Military Considerations
    Nolan, Colin F.
    CUTIS, 2022, 110 (06): : 316 - 320
  • [23] Janus kinase inhibitors for atopic dermatitis: a promising treatment modality
    Cartron, A. M.
    Nguyen, T. H.
    Roh, Y. S.
    Kwatra, M. M.
    Kwatra, S. G.
    CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2021, 46 (05) : 820 - 824
  • [24] Emerging Role of Janus Kinase Inhibitors for the Treatment of Atopic Dermatitis
    Singh, Rhea
    Heron, Courtney E.
    Ghamrawi, Rima, I
    Strowd, Lindsay C.
    Feldman, Steven R.
    IMMUNOTARGETS AND THERAPY, 2020, 9 : 255 - 272
  • [25] Efficacy and safety of Janus kinase selective inhibitors in the treatment of atopic dermatitis: A systematic review and meta-analysis
    Wang, Mingyue
    Gao, Xinghua
    Zhang, Li
    ALLERGY AND ASTHMA PROCEEDINGS, 2025, 46 (02) : 88 - 97
  • [26] Efficacy and safety of topical Janus kinase and phosphodiesterase inhibitor-4 inhibitors for the treatment of atopic dermatitis: A network meta-analysis
    Zhang, Lu
    Du, Dan
    Wang, Lian
    Guo, Linghong
    Jiang, Xian
    JOURNAL OF DERMATOLOGY, 2021, 48 (12): : 1877 - 1883
  • [27] Comparative Efficacy and Safety of Monoclonal Antibodies and Janus Kinase Inhibitors in Moderate-to-severe Atopic Dermatitis: A Systematic Review and Meta-analysis
    Sedeh, Farnam B.
    Henning, Mattias A. S.
    Jemec, Gregor B. E.
    Ibler, Kristina S.
    ACTA DERMATO-VENEREOLOGICA, 2022, 102
  • [28] Comparative safety of oral Janus kinase inhibitors versus dupilumab in patients with atopic dermatitis: A population-based cohort study
    Tsai, Serena Yun-Chen
    Phipatanakul, Wanda
    Hawryluk, Elena B.
    Oyoshi, Michiko K.
    Schneider, Lynda C.
    Ma, Kevin Sheng-Kai
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2024, 154 (05)
  • [29] The safety of systemic Janus kinase inhibitors in atopic dermatitis: A systematic review and meta-analysis of randomized controlled trials
    Yoon, Sanghyuk
    Kim, Kihun
    Shin, Kihyuk
    Kim, Hoon-Soo
    Kim, Byungsoo
    Kim, Moon-Bum
    Ko, Hyun-Chang
    Kim, Yun Hak
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2024, 38 (01) : 52 - 61
  • [30] The effectiveness of Janus kinase inhibitors in treating atopic dermatitis: A systematic review and meta-analysis
    Arora, Charan Jeet
    Khattak, Fakhre Alam
    Yousafzai, Mohammad Tahir
    Ibitoye, Bukola Mary
    Shumack, Stephen
    DERMATOLOGIC THERAPY, 2020, 33 (04)
12345